NPI registry status
Active
2026 NPPES data Internal Medicine Physician NPI 1295821478 MD
Verify on CMS → Ali Mortazavi, MD
Internal Medicine Physician in Houston, Texas.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 172,737 in Internal Medicine Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
4K
Medicare Part D claims · 644 beneficiaries · Internal Medicine Physician avg: 3K
Generic prescribing
92%
generic claims · 8% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$179
6 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2023
What the federal data shows
Ali Mortazavi, MD filed 4,286 Medicare Part D claims in 2023 as an Internal Medicine Physician in Houston, Texas, prescribing 92% generic.
- 4K
- Part D claims, 2023
- 92%
- generic prescribing
- Likely
- board-certified (heuristic)
- ≥92nd
- pct by Part D claim volume (lower-bound band)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Ali Mortazavi, MD's Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2023, across all CMS prescribers nationally
4,286 ≥ 92nd percentile 92% of 1,370,886 prescribers are in lower value bands
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.
Source CMS Medicare Part D Prescriber Public Use File · 2023
✓
Board certification likely (heuristic, not verified)
Ali Mortazavi, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Ali Mortazavi, MD?
Quality data not reportedPrimary specialty
Internal Medicine Physician
Medicare Part D claims
4,286 58% vs specialty avg
Specialty distribution in Texas
How Internal Medicine Physician compares to other specialties among Texas providers
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Internal Medicine Physician. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Ali Mortazavi, MD appears in the CMS NPPES registry as an Internal Medicine Physician provider holding MD credentials at 2727 W HOLCOMBE BLVD, Houston, TX, 77025, with a listed phone of (713) 442-0000. NPI 1295821478 was issued on 10/05/2006.
Medicare Part D records for calendar year 2023 show 4,286 prescription claims written by this provider, covering 644 Medicare beneficiaries and totaling roughly $325K in drug spend, split 8% brand-name and 92% generic by claim count.
Internal Medicine Physician is a high-volume specialty nationwide, with 172,737 enrolled providers across 56 states and an average of 2,716 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1295821478 |
|---|---|
| Specialty | Internal Medicine Physician |
| Credentials | MD |
| Gender | Male |
| NPI Issued | 10/05/2006 |
Hospital and facility affiliations
Facilities where Ali Mortazavi, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Kelsey-Seybold Medical Group, PLLC
Houston, TX
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Ali Mortazavi, MD. Source: openpaymentsdata.cms.gov.
Total received
$179
Largest payer
Abbott Laboratories
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - Texas TMB 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~77K Texas medical licensees in 2023 - they are NOT specific to Ali Mortazavi, MD. To verify Ali Mortazavi, MD's current license status, search the TMB public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
344
Total board actions, Texas 2023
Across 334 cases
4.47
Actions per 1,000 licensees
Texas statewide rate
probation
Most common action type
94 cases
TMB publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Texas disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Generic-heavy
Ali Mortazavi, MD - brand share 8.0%
Internal Medicine Physician average
8% brand-name claims vs 92% generic, on 4,286 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
4,286
Total Claims
$325K
Total Drug Cost
644
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 9,147
- Total Day Supply
- 266,727
- Brand vs Generic
- 8% brand / 92% generic
- Brand Drug Cost
- $250K
- Generic Drug Cost
- $75K
- Antibiotic Claims
- 214
Patient Demographics
- Average Patient Age
- 77.5 years
- Avg HCC Risk Score
- 1.95
- Gender Split
- 38% female / 62% male
- Age Distribution
- <65: 12, 65-74: 222, 75-84: 294, 85+: 116
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Ali Mortazavi, MD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Clopidogrel
Clopidogrel
479 claims
- Atorvastatin Calcium
Atorvastatin Calcium
450 claims
- Carvedilol
Carvedilol
354 claims
- Metoprolol Tartrate
Metoprolol Tartrate
309 claims
- Eliquis
Eliquis
235 claims
- Metoprolol Succinate
Metoprolol Succinate
219 claims
- Losartan Potassium
Losartan Potassium
201 claims
- Minocycline Hcl
Minocycline Hcl
198 claims
| Drug | Claims |
|---|---|
| Clopidogrel Clopidogrel Bisulfate | 479 |
| Atorvastatin Calcium | 450 |
| Carvedilol | 354 |
| Metoprolol Tartrate | 309 |
| Eliquis Apixaban | 235 |
| Metoprolol Succinate | 219 |
| Losartan Potassium | 201 |
| Minocycline Hcl | 198 |
| Rosuvastatin Calcium | 195 |
| Lisinopril | 184 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Internal Medicine Physician Overview
How Ali Mortazavi, MD fits within the Internal Medicine Physician landscape nationally.
172,737
Internal Medicine Physician Providers in US
56
States with Internal Medicine Physician
2,716
Avg Claims per Provider
Ali Mortazavi, MD's 4,286 claims are above the specialty average of 2,716.
Nearby Internal Medicine Physician Providers in Texas
Other clinicians with the same primary specialty enrolled in Texas, drawn from the same CMS NPPES roster as Mortazavi.
Dr. Muhammad A. Sattar
MD
Dallas, TX
Anunaya Aashish
Denton, TX
Dr. Queenie Ann Abad
M.D.
San Antonio, TX
Dr. Fuad Abaleka
M.D
Lubbock, TX
Dr. Carol Abalihi
M.D.
El Paso, TX
Compare Internal Medicine Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the Texas medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Internal Medicine Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
How to Find a Doctor
Step-by-step guide to choosing a provider
Verify Credentials
Check NPI, board certification & license status
Medical Specialties Explained
Who treats what and how specialties differ
Understanding Medicare Claims Data
What prescribing data reveals about a provider
In-Network vs Out-of-Network
How insurance networks affect your costs
Telehealth Guide
Virtual care options and coverage in 2026
Explore Texas
Frequently Asked Questions
What is Ali Mortazavi, MD's specialty? ▼
Ali Mortazavi, MD specializes in Internal Medicine Physician and practices in Houston, Texas. Credentials: MD.
How much does Ali Mortazavi, MD prescribe under Medicare Part D? ▼
In 2023, Ali Mortazavi, MD wrote 4,286 Medicare Part D claims totaling $325K in drug costs for 644 beneficiaries.
Where is Ali Mortazavi, MD located? ▼
Ali Mortazavi, MD is located at 2727 W HOLCOMBE BLVD, Houston, TX, 77025. Phone: (713) 442-0000.
What is Ali Mortazavi, MD's NPI number? ▼
Ali Mortazavi, MD's National Provider Identifier (NPI) is 1295821478, issued on 10/05/2006.
Does Ali Mortazavi, MD prescribe more brand-name or generic drugs? ▼
Ali Mortazavi, MD's prescribing is 8% brand-name and 92% generic drugs by claim count, with $250K in brand drug costs.
How many Internal Medicine Physician providers are there in the US? ▼
There are 172,737 Internal Medicine Physician providers across 56 states in the US. The average Internal Medicine Physician provider writes 2,716 Medicare Part D claims per year.
What drugs does Ali Mortazavi, MD prescribe most often? ▼
Based on 2023 Medicare Part D data, Ali Mortazavi, MD's most frequently prescribed drugs include Clopidogrel, Atorvastatin Calcium, Carvedilol. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Ali Mortazavi, MD accept Medicare? ▼
Ali Mortazavi, MD appears in CMS Medicare data with 4,286 Part D claims and 644 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Ali Mortazavi, MD's credentials? ▼
Ali Mortazavi, MD's NPI is 1295821478 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.